UB
VIR icon

UMB Bank’s Vir Biotechnology VIR Stock Holding History

UMB Bank’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$200K Buy
19,624
+52
+0.3% +$495 ﹤0.01% 732
2026
Q1 		$175K Buy
19,572
+12,510
+177% +$99.7K ﹤0.01% 732
2025
Q4 		$42.6K Buy
7,062
+6,597
+1,419% +$39.3K ﹤0.01% 1300
2025
Q3 		$2.65K Sell
465
-63
-12% -$322 ﹤0.01% 2010
2025
Q2 		$2.66K Buy
528
+104
+25% +$558 ﹤0.01% 1964
2025
Q1 		$2.75K Buy
424
+160
+61% +$1.42K ﹤0.01% 1913
2024
Q4 		$1.94K Buy
264
+222
+529% +$1.75K ﹤0.01% 1948
2024
Q3 		$315 Sell
42
-75
-64% -$651 ﹤0.01% 2121
2024
Q2 		$1.04K Buy
117
+71
+154% +$681 ﹤0.01% 1964
2024
Q1 		$466 Buy
+46
New +$468 ﹤0.01% 1998
2023
Q4 		– Sell
-1,549
Closed -$14.5K – 1754
2023
Q3 		$14.5K Buy
+1,549
New +$22.1K ﹤0.01% 1164

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

UMB Bank's VIR Position: Q2 2026 in Review

UMB Bank increased its Vir Biotechnology (VIR) stake by 0.27% in Q2 2026, buying an estimated $495 and bringing the position to 19,624 shares worth $200K. The position accounts for ﹤0.01% of the portfolio, ranked #732.

UMB Bank first reported a position in VIR in Q3 2023 and has held it in 11 quarters since. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • UMB Bank held 19,624 shares of Vir Biotechnology worth $200K as of Q2 2026.
  • UMB Bank bought 52 Vir Biotechnology shares in Q2 2026, an estimated $495.
  • Vir Biotechnology made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #732 holding.
  • UMB Bank first reported a position in Vir Biotechnology in Q3 2023 and has held it in 11 quarters since.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.